Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 30, 16:00
315.90
7.9 (2.56%)
VOLUME 18,594
LIVE
NSE
Mar 30, 15:55
316.05
7.8 (2.53%)
VOLUME 180,478
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Book profits on rallies as Nifty is witnessing a ‘Bearish Butterfly’ on the charts

10.07 am | 24 Dec 2017 |  Source: Moneycontrol.com

Jay Purohit, Technical & Derivatives Analyst at Centrum Broking Limited, says short-term traders are advised to book some profit at current levels....

Strides Shasun buys controlling stake in South African drug co Trinity Pharma for Rs 27.5 cr

5.41 pm | 20 Dec 2017 |  Source: Moneycontrol.com

The transaction provides access to pipeline of more than 110 product dossiers already submitted in addition to an important platform for Strides' ...

Strides acquires controlling stake in South Africa's Trinity

12.51 pm | 20 Dec 2017 |  Source: PTI

"Strides Pharma Asia Pte, Singapore, a wholly-owned subsidiary of Strides Shasun has entered into definitive agreements with Trinity Pharma Proprietar...

Strides Shasun acquires controlling stake in Trinity Pharma, South Africa

11.13 am | 20 Dec 2017 |  Source: Moneycontrol.com

Strides Pharma Asia Pte, Singapore, a wholly owned subsidiary of Strides Shasun has entered into definitive agreements with Trinity Pharma proprietary...

News highlights for the day: Centre to table triple talaq bill in Parliament tomorrow

7.13 am | 20 Dec 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Strides Shasun: Notice Of Tribunal Convened General Meeting to be held on December 27, 2017

12.03 pm | 25 Nov 2017 |  Source: Moneycontrol.com

Strides Shasun has informed about Notice of Tribunal Convened General Meeting to be held on December 27, 2017....

Strides Shasun gets USFDA nod for altitude sickness tablets

1.08 pm | 22 Nov 2017 |  Source: PTI

In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for Acetazolamid...

News highlights of the day: Modi a 'serial abuser': Congress spokesperson Abhishek Manu Singhvi

7.00 am | 22 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Buy Strides Shasun; target of Rs 1200: HDFC Securities

6.22 pm | 21 Nov 2017 |  Source: Moneycontrol.com

HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated 21 No...

Eris Lifesciences buys Strides Shasun's India branded business for Rs 500 crore

4.59 pm | 18 Nov 2017 |  Source: Moneycontrol.com

Strides’ India branded generics business comprises of a portfolio of 130 plus brands in the domains of neurology, psychiatry, nutraceuticals and gas...

Buy Strides Shasun; target of Rs 1201: Motilal Oswal

4.15 pm | 13 Nov 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Shasun has recommended Buy rating on the stock with a target price of Rs 1201 in its research report dated October...

Strides Shasun Q2 net profit dives 87% to Rs 10.73 cr

4.50 pm | 31 Oct 2017 |  Source: PTI

The company had posted a net profit of Rs 85.43 crore for the corresponding period of the previous fiscal, Strides Shasun said in a filing to BSE....

Australia biz expanded; rebounded strongly in India & EMs: Strides Shasun 

4.11 pm | 31 Oct 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Shashank Sinha, Managing Director of Strides Shasun spoke about the results and his outlook for the company....

Strides Shasun declares Q2 numbers, cons adjusted profit at Rs 23.8cr

2.19 pm | 31 Oct 2017 |  Source: Moneycontrol.com

Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2017...

Sell Strides Shasun, Siemens, Jet Airways; buy HCL Tech, Britannia: Sudarshan Sukhani 

10.51 am | 12 Oct 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Strides Shasun, Siemens and Jet Airways and can buy HCL Technologies and Britann...

Will be vertically integrated formulation company: Strides Shasun 

4.07 pm | 25 Sep 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Shashank Sinha, MD & GROUP CEO of Strides Shasun spoke about the latest happenings in his company and sector....

Strides Shasun receives USFDA approval for Omega-3-Acid Ethyl Esters capsules

10.41 am | 20 Sep 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from the USFDA approval for Omega-3-Acid Ethyl Esters capsules, a generic version of Lovaza....

Cabinet approves 78 days productivity-linked bonus for rail employees

7.33 am | 20 Sep 2017 |  Source: Moneycontrol.com

ITDC’s Hotel Jaipur Ashok and Lalitha Mahal Palace Hotel, Mysore is to be transferred to the Rajasthan and Karnataka government, respectively....

Strides Shasun: Outcome of AGM

4.16 pm | 15 Sep 2017 |  Source: Moneycontrol.com

Strides Shasun has informed about the outcome of AGM....

Buy Strides Shasun; target of Rs 1300: Motilal Oswal

3.48 pm | 14 Sep 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated Septemb...

1 2 3 4
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.